GCG and type 2 diabetes mellitus: Clinical studies have shown that infusion of exogenous GLP-1 decreases the glycaemic response to enteral nutrition in critically ill patients, including those with preexisting type 2 diabetes [34, 35]; however, the sensitivity to exogenous GIP is impaired, as has also been reported in type 2 diabetes [30].